Natallie Rocha

Reporter

Email: nrocha@sdbj.com
Phone: 858-277-6359 Extension: 3120

Recent Stories

Tentarix Biotherapeutics Secures $50 Million

BIOTECH: Series A Supports Precision Therapy Platform

Tentarix Biotherapeutics secured $50 million in Series A funding to back the development of its novel biotherapeutics platform.

Tease photo

Radionetics Oncology Launches with $30M Investment

BIOTECH: New Co. Spins Out of Crinetics Pharmaceuticals

Radionetics Oncology, a pharmaceutical company developing radiotherapeutics, launched with $30 million in funding from major life science investors 5AM Ventures and Frazier Healthcare Partners.

Tease photo

NanoCellect Raises $35M

BIOTECH: Local Investors Back Co.

NanoCellect Biomedical, Inc. brought in $35 million in Series C and D funding to advance its microfluidic cell sorting solutions. Local investors such as FusionX Ventures, Anzu Partners and Agilent Technologies are among those backing the San Diego biotech.

Tease photo

San Diego Scientists Advance Oncology Innovation

Biotechnology and Biopharmaceutical Companies Delivering New Treatments to Fight Cancer

Among the many segments of life changing work being done in San Diego’s life science community, cancer research has a strong presence.

Tease photo

Healthcare Technologies Adapt to Patient Needs

Consumer-Facing Technologies and Apps Are Digital Tools for Local Providers

Healthcare organizations have transformed their offerings to meet patients where they are at. San Diego healthcare providers are using digital platforms and consumer-facing apps to streamline care options for their patients with everything from scheduling appointments to telehealth visits.

Palomar Health CEO Honored

HEALTHCARE: Hansen Wins Leadership Award

Diane Hansen, president and CEO of Palomar Health won the CEO of the Year award from The Association of California Healthcare Districts for her leadership and transformation of the North County healthcare district.

Tease photo

INOVIO Advances COVID-19 Vaccine Trials

BIOTECH: Co. Moves Forward in Mexico, Brazil and the Philippines

INOVIO Pharmaceuticals (NASDAQ: INO), a biotechnology company designing DNA medicines, received approval from Mexico’s national health regulatory agency to advance its COVID-19 vaccine candidate to Phase 3 clinical trials.

Tease photo

Cue Health Goes Public

BIOTECH: IPO Raises $200M

Cue Health rang the opening bell on the Nasdaq to celebrate its first day as a publicly traded company on Sept. 24. The San Diego-based health technology company, which makes digital diagnostic testing solutions including a COVID-19 molecular test, raised $200 million through its IPO.

Tease photo

Endeavor BioMedicines Tackles Root Cause of Diseases

MEDICINE: Growing Co. Inks Licensing Deal with Salk Institute and Sanford Burnham Prebys

Endeavor BioMedicines, a clinical-stage precision medicine company, signed an exclusive licensing deal with the Salk Institute for Biological Studies and Sanford Burnham Prebys for a ULK1/2 inhibitor program to broaden the company’s precision oncology pipeline.

Agena Acquired for $300M

BIOTECH: Co. to Remain in S.D.

San Diego-based Agena Bioscience, Inc. agreed to be acquired by Mesa Laboratories, Inc. (NASDAQ:MLAB) for a purchase price of $300 million.

Cue Health Enters the Public Market

Company valuation of $2.3 billion at IPO

Tease photo

Replicate Bioscience Exits Stealth Mode

BIOTECH: Firm Invests in RNA Treatments

Replicate Bioscience, a startup developing a pipeline of RNA-based treatments, exited stealth mode on Sept. 8 with $40 million in Series A backing its launch.

Jumpcode to Help Sequence COVID-19

BIOTECH: Co. Partners With Research Institute

Jumpcode Genomics, a local genome technology company, has partnered with the Translational Genomics Research Institute (TGen) to help sequence and examine the genomic epidemiology of SARS-CoV-2, the virus that causes COVID-19.

Tease photo

Cue Health to Sell 12 Million Shares in IPO

Cue Health will offer 12.5 million common shares for a range of $15 to $17 per share, according to its amended IPO.

Advanced BioMatrix Acquired for $15 Million

BIOTECH: San Diego Co. Joins BICO’s Bioprinting Business

Advanced BioMatrix, a San Diego biotech that creates products for 3D applications including cell cultivation, cell assays and bioprinting, was acquired by BICO Group AB (STO: BICO) for approximately $15 million.

Plantible Foods Nets $21.5M Series A Funding

BIOTECH: Ag-Tech Co. Aims to Change Food Supply Chain

Plantible Foods, a local agriculture-tech start-up developing a plant-based protein, raised $21.5 million in Series A funding.

Tease photo

Scientist.com Acquires InsideScientific

Scientist.com expands its offerings of "biotech as a service” (BaaS) platform

Tease photo

ARS Pharma Raises $55M

MEDICINE: Funding Backs Product Launch

ARS Pharmaceuticals, a pre-commercial pharmaceutical company, raised $55 million in Series D funding to back preparations for the launch of its lead product Neffy, an epinephrine nasal spray.

iBio to Grow Talent in S.D.

BIOTECH: Co. Develops Plant-Based Therapies

iBio, Inc. (NYSEA: IBIO), a company that produces plant-based antibodies for therapeutics and vaccines, has joined the growing number of life science companies choosing to expand their operations in San Diego.

Tease photo

Codex DNA Releases Full-Length Synthetic Genome for Highly Infectious SARS-CoV-2 Delta Variant

Codex DNA released full-length synthetic genome of COVID-19 Delta variant virus.

Cue Health Files for IPO

Cue Health filed an initial public offering on Sept. 1.

Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application

FDA clears the company's first fully allogeneic CAR-T product candidate for patients with relapsed/refractory multiple myeloma.

TOOTRiS Named Finalist in U.S. Chamber of Commerce Annual Dream Big Awards

San Diego start-up TOOTRiS is one of three finalists for the Minority-Owned Business Achievement Award.

Advanced BioMatrix Acquired by BICO for $15M

San Diego-based Advanced BioMatrix acquired for $15 million.

BioSurplus in 3-Way Merger

BIOTECH: Co. Formed As One-Stop-Shop

Local life science company, BioSurplus, joined Massachusetts-based Biodirect and Boston Microscopes in a three-way merger to form Copia Scientific.

NuVasive’s Q2 Earnings Up 45%

BIOTECH: Co. Increases Investment in R&D

San Diego medical device company, NuVasive (NASDAQ: NUVA) recorded $294.8 million in net sales for the second quarter 2021 — a 44.8% increase from the previous year’s same period.

Tease photo

INOVIO Gets Authorization for Phase 3 Trials of COVID-19 Vaccine Candidate

BIOTECH: Brazil’s Regulatory Agency Gives the Co. Green Light

INOVIO received authorization from Brazil's ANVISA (Agência Nacional de Vigilância Sanitária) to initiate a global Phase 3 efficacy trial for INO-4800, its DNA vaccine candidate for COVID-19.

USD Students Land Internships to Jump Start Real Estate Careers

EDUCATION: ICSC Foundation Launch Academy Offers Program to Diversify Industry Opportunities

Earlier this year, three University of San Diego School of Business undergraduate real estate students were awarded internships by the ICSC Foundation Launch Academy.

Artiva Biotherapeutics Announces New San Diego Facility

BIOTECH: R&D and GMP Manufacturing Center to Open in 2022

Artiva Biotherapeutics, a clinical-stage biotech company developing off-the-shelf, allogeneic, natural killer (NK) cell-based therapies, will establish a 52,000 square foot research and manufacturing center at its San Diego headquarters.

Tease photo

Qualcomm Launches First 5G, AI Enabled Drone Program

TECH: Platform Offers Customizable Design

Qualcomm unleashed the first ever 5G and artificial intelligence (AI) enabled drone program on Aug. 17.

Tease photo

ResMed Reports $3.2 Billion in Revenue

BIOTECH: Demand Growing; New Product Launched

ResMed, the leading global manufacturer in sleep apnea therapy, reported their Q4 earnings on Aug. 5 and recorded $876.1 million in revenue.

Tease photo

San Diego-based BioSurplus Merges to Form Copia Scientific

BioSurplus CEO to become head of the combined company

Tease photo

Illumina Moves Forward with Acquisition of GRAIL

GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review

Tease photo

Helping the Life Science Industry Accelerate R&D

San Diego’s Biotech Boom Backed By Research Institutions and Contract Organizations

Local life science companies big and small have been going public and securing funding to advance their research and drug pipelines in what could be described as a biotech boom.

Tease photo

City of San Diego Signs Multi-Million-Dollar Contract with Zensar Technologies

One of the largest cities in the U.S. goes full tech

Blue Shield Provides $500K to Develop Mental Health Workforce

HEALTHCARE: Program Helping Disadvantaged Young People Explore Careers in Psychological Wellness

Blue Shield of California dedicated $500,000 to support local mental health organizations such as National Alliance on Mental Illness in San Diego (NAMI San Diego) to develop a more diverse workforce.

Engrail Therapeutics Extends Series A to $64 Million

Series A funding round led by Nan Fung Life Sciences (NFLS)

Turquoise Health Raises $5 Million in Seed Funding

BIOTECH: Co. Developing Healthcare Price Transparency Platform

Local startup, Turquoise Health, raised $5 million in seed funding to back its healthcare price transparency and provider-payer contract negotiation platform that generates cost certainty for patients.

BioLegend to Be Acquired for $5.25 Billion

BIOTECH: San Diego Facility Becomes Global Center of Excellence

BioLegend, a global developer and manufacturer of antibodies and reagents, agreed to be acquired by PerkinElmer for approximately $5.25 billion in cash and stock, the companies announced on July 26.

Tease photo

Stemson Therapeutics Closes $15M Series A

BIOTECH: Co. Working on Genetic Therapy for Hair Loss

Stemson Therapeutics, a biotech company working on a cure for hair loss, closed a $15 million Series A funding round on July 15.

Tease photo

PerkinElmer Agrees to Acquire BioLegend

Deal worth approximately $5.25 billion

Wugen Secures $172M Series B

BIOTECH: Funding Backs Cell Therapy

Wugen, Inc. raised $172 million in Series B funding to advance its pipeline of off-the-shelf cell therapies for cancer. The oversubscribed financing will also help the Missouri-based biotech grow its presence in San Diego.

Tease photo

PacBio Acquires San Diego Startup Omniome

Pacific Biosciences will acquire San Diego-based Omniome in deal worth up to $800M

Tease photo

Poseida Partners with Cellares to Streamline Genetic Manufacturing

BIOTECH: Co. Gains Access to Cell Shuttle Technology

Poseida Therapeutics (Nasdaq: PSTX) announced a partnership with Bay-area start-up, Cellares Corporation to utilize its technology platform to accelerate cell manufacturing.

Stelios Therapeutics Acquired

Local biotech, Stelios Therapeutics, acquired by LEXEO Therapeutics

Avidity Biosciences CEO Reflects on Going Public in 2020

BIOTECH: Sarah Boyce Speaks About Completely Virtual IPO Process

The past year has changed everything about what it means for a biotech company to go public, according to Avidity Biosciences President and CEO Sarah Boyce.

Tease photo

Uqora Acquired by Pharmavite

BIOTECH: Co. Joins Maker of Nature Made

Pharmavite, the maker of Nature Made vitamins and supplements, acquired local life science company Uqora Inc. to expand its offerings of women’s health products.

Tease photo

Ensysce Biosciences Closes SPAC Merger

BIOTECH: Latest Example of San Diego Life Science Cos. Going Public

Ensysce Biosciences is the latest local company to join the public market after closing the merger deal on July 1. The company will be trading its common stock on the Nasdaq under the ticker symbol “ENSC” and warrants under the ticker symbol “ENSCW” on the OTC Market.

Cortica, Inc. Secures $60 Million Series C Funding

HEALTHCARE: Co. Plans to Expand Autism Care Model

Cortica, Inc. secured $60 million in Series C funding to expand its technology-centered care model for children with autism and neurodevelopmental differences.

Tease photo

Erasca, Inc. Prices IPO

Clinical-Stage Biotech Offers Over 17 Million Shares

Prev